The Intellectual Crisis of Psychiatric Research
The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Abstract
The aim of this paper was to examine the intellectual crisis and the potential sources of reveille in clinical research in psychiatry. Current prevailing conceptual models in psychiatry are critically examined, with particular reference to neurobiology, clinical psychopharmacology, assessment, and the therapeutic process. Biological reductionism, neglect of individual responses to treatment, massive propaganda from the pharmaceutical industry, misleading effects of psychometric theory on clinical assessment, and lack of consideration of multiple therapeutic ingredients and of the role of psychological well-being are identified as major sources of an intellectual crisis in psychiatric research. The conceptual crisis of psychiatry is shared by other areas of clinical medicine and stems from a narrow concept of science that neglects clinical observation, the basic method of medicine. A unified concept of health and disease may yield new clinical insights in psychiatric disorders, and may result in therapeutic efforts of more enduring quality than current strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These pathways include biological, psychological, and social factors of iatrogenic nature, whose consequences (syndromes, symptoms and any sort of problem) may be considered as potentially counter-therapeutic [72].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [72]
Citations
Cites
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733 · cited 1×
“published a paper on the dynamic balance between health and disease: A person may satisfy all the criteria of health at any point in time simply because the adaptive capacity of a defective system – be it biochemical, physiological, or psychological – has not been exceeded. This may be a matter of fortunate circumstan…”
BackgroundBelmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
Psychological well-being: Meaning, measurement, and implications for psychotherapy research
Ryff, C. D., & Singer, B. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000289026 · Cited by 1,295
Publication bias in meta-analysis its causes and consequences
Thornton, A. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00161-4 · Cited by 1,291 · cited 1×
“The various methods for detecting and correcting for publication bias, though useful, all have limitations [”
MethodThe Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148
Problems in the “Evidence” of “Evidence-Based Medicine”
Feinstein, A. R., & Horwitz, R. I. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00244-1 · Cited by 653 · cited 1×
“p. 333]. A further weakness of meta-analyses is the fact that randomized controlled trials refer to an average patient who fulfilled the criteria for admission. An issue which is neglected is the fact that, when transferred to clinical medicine from their origin in agricultural research, randomized trials were not int…”
BackgroundTesting for Qualitative Interactions between Treatment Effects and Patient Subsets
Gail, M., & Simon, R. (1985) · Biometrics · doi:10.2307/2530862 · Cited by 651
Melander, H., Ahlqvist-Rastad, J., Meijer, G., & Beermann, B. (2003) · BMJ · doi:10.1136/bmj.326.7400.1171 · Cited by 635
Fava, M., & Kendler, K. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00112-4 · Cited by 603
Toward a Philosophical Structure for Psychiatry
Kendler, K. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.433 · Cited by 561 · cited 1×
“An increasing number of psychiatrists are wondering, however, why the cures and clinical insights that the neurosciences have promised have not taken place. Biological reductionism [”
BackgroundMedical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies
Smith, R. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020138 · Cited by 498 · cited 1×
“This calls for a reassessment of basic pathophysiological models of pathogenesis, which are based on flat and cross-sectional instead of longitudinal views of disorders. Corners of Myopia in Clinical Psychopharmacology In the past decade the issue of conflict of interest has progressively gained importance in clinical…”
Fava, M., Evins, A. E., Dorer, D. J., & Schoenfeld, D. A. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000069738 · Cited by 452
Financial Anatomy of Biomedical Research
Moses, H., Dorsey, E. R., Matheson, D. H. M., & Thier, S. O. (2005) · JAMA · doi:10.1001/jama.294.11.1333 · Cited by 447 · cited 1×
“and simply attempts to apply oversimplified neurobiological models to the understanding and treatment of mental disorders. Enhancing the benefits of research where clinical need is greatest, and not only where commercial opportunity is perceived, is a current priority of medicine [”
Background(1987) · PubMed · Cited by 439
How Should Remission From Depression Be Defined? The Depressed Patient’s Perspective
Zimmerman, M., McGlinchey, J. B., Posternak, M. A., Friedman, M., Attiullah, N., & Boerescu, D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.148 · Cited by 431
Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders
FAVA, G. A., RAFANELLI, C., CAZZARO, M., CONTI, S., & GRANDI, S. (1998) · Psychological Medicine · doi:10.1017/s0033291797006363 · Cited by 427
Self-citationModern antipsychotic drugs: a critical overview
Gardner, D. M. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041064 · Cited by 422 · cited 1×
“from the massive amount of propaganda delivered by medical journals and meetings?The place of atypical antipsychotics in clinical practice is a good exemplification of this problem. Even though current evidence suggests to consider both older and newer drugs, because of growing concerns about potential adverse long-te…”
Background“A Gene for…”: The Nature of Gene Action in Psychiatric Disorders
Kendler, K. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1243 · Cited by 401
Fava, G. A., & Ruini, C. (2003) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/s0005-7916(03)00019-3 · Cited by 386
Self-citationContribution of life events to causation of psychiatric illness
Paykel, E. S. (1978) · Psychological Medicine · doi:10.1017/s003329170001429x · Cited by 372
Multiplicity in randomised trials II: subgroup and interim analyses
Schulz, K. F., & Grimes, D. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66516-6 · Cited by 357
Well-Being Therapy of Generalized Anxiety Disorder
Fava, G. A., Ruini, C., Rafanelli, C., Finos, L., Salmaso, L., Mangelli, L., & Sirigatti, S. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000082023 · Cited by 344
Self-citationMeta-analysis: Statistical alchemy for the 21st century
Feinstein, A. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00110-c · Cited by 339 · cited 1×
“Treatment Ingredients and Evidence-Biased Psychiatry In the past decade, the concept of evidence-based medicine has achieved wide currency in all fields of medicine, including psychiatry. Alvan Feinstein [”
BackgroundA Unified Concept of Health and Disease
Engel, G. L. (1960) · Perspectives in Biology and Medicine · doi:10.1353/pbm.1960.0020 · Cited by 336
Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1957 · Cited by 318
Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications
FAVA, G. A. (1999) · Psychological Medicine · doi:10.1017/s0033291798007429 · Cited by 258 · cited 1×
“But what is its translational value?Further, a prodromal phase can be described in most instances of mood and anxiety disorders [”
BackgroundSelf-citationCan long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223
Self-citationLines of Evidence on the Risks of Suicide with Selective Serotonin Reuptake Inhibitors
Healy, D. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000068691 · Cited by 220
Frances, R. J. (2007) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70411-0 · Cited by 220
Wright, J. G., & Feinsten, A. R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90161-f · Cited by 212
Life events, depressive relapse and maintenance treatment
Paykel, E. S., & Tanner, J. (1976) · Psychological Medicine · doi:10.1017/s0033291700015920 · Cited by 178 · cited 1×
“Psychosocial factors, such as the role of life events in causing depressive relapse during maintenance treatment [”
BackgroundLoss of Antidepressant Efficacy During Maintenance Therapy: Possible Mechanisms and Treatments
Byrne, S. E., & Rothschild, A. J. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0602 · Cited by 149
Zimmerman, M., Chelminski, I., & Posternak, M. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1370 · Cited by 144
Psychometric Theory Is an Obstacle to the Progress of Clinical Research
Fava, G. A., Ruini, C., & Rafanelli, C. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000076451 · Cited by 140 · cited 1×
“remarks, the effect of psychometric theory on psychiatric assessment is that of considering an illness as the sum of its symptoms, which, in turn, are represented by the numbers associated with specific behaviors.It has been suggested [”
BackgroundSelf-citationDrug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy
UHLENHUTH, E. H., Rickels, K., Fisher, S., Park, L. C., Lipman, R. S., & MOCK, J. (1966) · Psychopharmacology · doi:10.1007/bf00406450 · Cited by 123 · cited 1×
“When these non-specific therapeutic ingredients are missing, drugs are unlikely to be superior to placebo [”
BackgroundMcDowell, I. (2006) · Measuring Health · doi:10.1093/acprof:oso/9780195165678.003.0005 · Cited by 121
Horwitz, R. I., Singer, B. H., Makuch, R. W., & Viscoli, C. M. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00058-5 · Cited by 116
The Concept of Recovery in Affective Disorders
Fava, G. A. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000289025 · Cited by 113
Self-citationFava, G. A. (2016) · The Wiley Handbook of Positive Clinical Psychology · doi:10.1002/9781118468197.ch26 · Cited by 105
Self-citationSequential Treatment of Mood and Anxiety Disorders
Fava, G. A., Ruini, C., & Rafanelli, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1108 · Cited by 103 · cited 1×
“and implementation of sequential treatment strategies [”
Self-citationPart 2. Improvement criteria in drug trials with neurotic patients
Kellner, R. (1972) · Psychological Medicine · doi:10.1017/s0033291700045645 · Cited by 103
Reduction of Symptoms by Pharmacologically Inert Substances and by Short-Term Psychotherapy
GLIEDMAN, L. H. (1958) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1958.02340030109018 · Cited by 92
The Sesto Fiorentino Study: Background, Methods and Preliminary Results
Faravelli, C., Abrardi, L., Bartolozzi, D., Cecchi, C., Cosci, F., D’Adamo, D., Lo Iacono, B., Ravaldi, C., Scarpato, M. A., Truglia, E., et al. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000077740 · Cited by 89
The Clinical Domains of Psychosomatic Medicine
Fava, G. A., & Sonino, N. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0707 · Cited by 88 · cited 1×
“Therapeutic results are always the result of several ingredients, which may be specific or non-specific [”
BackgroundSelf-citationRethinking Models of Psychotropic Drug Action
Moncrieff, J., & Cohen, D. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000083999 · Cited by 88 · cited 1×
“instead of accepting the possibility that a specific drug may be harmful to that specific patient.Another important and yet seldom discussed issue is the fact that psychotropic drugs are believed to work by acting on a disease process, which the propaganda translates into ‘curing’ psychiatric diseases. However there i…”
BackgroundFaravelli, C., Abrardi, L., Bartolozzi, D., Cecchi, C., Cosci, F., D’Adamo, D., Lo Iacono, B., Ravaldi, C., Scarpato, M. A., Truglia, E., et al. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000077741 · Cited by 85
Resuscitating clinical research in the United Kingdom
Bell, J. (2003) · BMJ · doi:10.1136/bmj.327.7422.1041 · Cited by 84
Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms?
Sareen, J., Kirshner, A., Lander, M., Kjernisted, K. D., Eleff, M. K., & Reiss, J. P. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.03.011 · Cited by 79
Modern Psychometrics in Clinimetrics: Impact on Clinical Trials of Antidepressants
Bech, P. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000076448 · Cited by 73
Psychiatry: Mindless or Brainless, Both or Neither?
Lipowski, Z. J. (1989) · The Canadian Journal of Psychiatry · doi:10.1177/070674378903400318 · Cited by 71
PRODROMAL SYMPTOMS IN MYOCARDIAL INFARCTION
Mounsey, P. (1951) · Heart · doi:10.1136/hrt.13.2.215 · Cited by 71
Zimmerman, M., Chelminski, I., & Young, D. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1016 · Cited by 71
The Use of Placebo in Clinical Trials on Bipolar Disorder: A New Approach for an Old Debate
Vieta, E., & Carné, X. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000082021 · Cited by 70
Faravelli, C. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000076449 · Cited by 63 · cited 1×
“At least five of a set of nine symptoms should be present. However, according to the psychometric model, all items are weighed the same, unlike in clinical medicine, where major and minor symptoms are often differentiated (e.g., the Jones criteria for rheumatic fever). As a result, a patient with severe and pervasive…”
BackgroundAn Experimental Approach to Diagnostic Psychological Testing
Shapiro, M. B. (1951) · Journal of Mental Science · doi:10.1192/bjp.97.409.748 · Cited by 63 · cited 1×
“Because the phenomena under observation in the development of psychometric principles were not clinical, it is not surprising they could not be adapted to psychiatry. In 1951, Shapiro [”
BackgroundSubclinical Symptoms of Panic Disorder: New Insights into Pathophysiology and Treatment
Fava, G. A., & Mangelli, L. (1999) · Psychotherapy and Psychosomatics · doi:10.1159/000012345 · Cited by 62
Self-citationZimmerman, M., Posternak, M. A., & Chelminski, I. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155824.59585.46 · Cited by 58
Physician-scientists and scientific physicians
Engel, G. L. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90384-6 · Cited by 57
The Intellectual Crisis in Clinical Science: Medaled Models and Muddled Mettle
Feinstein, A. R. (1987) · Perspectives in Biology and Medicine · doi:10.1353/pbm.1987.0047 · Cited by 54
A discussion on the role of clinimetrics and the misleading effects of psychometric theory
Fava, G. A., & Belaise, C. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.12.006 · Cited by 54 · cited 1×
“Historically, psychiatry had to draw its measurement tools from the field of psychometrics. The development of psychometrics, however, had taken place outside the clinical field, mainly in the educational and social areas [”
BackgroundSelf-citationSuicidal Ideation and Depressive Mixed States
Benazzi, F. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000082029 · Cited by 48 · cited 1×
“which may be potentially related to specific subgroups [”
BackgroundEditor's Comment: The Crisis in Clinical Research
Andreasen, N. C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.4.455 · Cited by 45
Prodromal Symptoms in Myocardial Infarction
Ottolini, F., Modena, M. G., & Rigatelli, M. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000086324 · Cited by 44
Physicians and the Investment Industry
Topol, E. J. (2005) · JAMA · doi:10.1001/jama.293.21.2654 · Cited by 44
Gaudiano, B. A., & Herbert, J. D. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000082022 · Cited by 43
Assay Sensitivity, Failed Clinical Trials, and the Conduct of Science
Otto, M. W., & Nierenberg, A. A. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000064813 · Cited by 42 · cited 1×
“p. 78]. A final problem lies in publication bias. Most of the negative trials concerned with psychotropic drugs do not get published [”
BackgroundPharmaceutical advertising revenue and physician organizations: how much is too much?
Glassman, P. A., Hunter-Hayes, J., & Nakamura, T. (1999) · PubMed · Cited by 40
The Aftermath of the Concept of ‘Psychiatric Comorbidity’
Maj, M. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000083164 · Cited by 40
The Additional Value of Clinimetrics Needs to Be Established rather than Assumed
Emmelkamp, P. M. G. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000076450 · Cited by 35
Independent clinical research in Europe
Remuzzi, G., Schieppati, A., Boissel, J., Garattini, S. K., & Horton, R. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17360-1 · Cited by 35
From Clinical Observations to Clinimetrics: A Tribute to Alvan R. Feinstein, MD
Nierenberg, A. A., & Sonino, N. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000076447 · Cited by 31
Continued Needs for Epidemiological Studies of Mental Disorders in the Community
Wittchen, H.-U. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000077738 · Cited by 30 · cited 1×
“Not surprisingly, the relevance of current epidemiological studies for identifying the potential for breakdown in the apparently healthy individual has been questioned [”
BackgroundClinical Observation: The Neglected Basic Method of Medicine
Engel, G. L. (1965) · JAMA · doi:10.1001/jama.1965.03080230055014 · Cited by 27
Conflict of Interest in Psychopharmacology: Can Dr. Jekyll Still Control Mr. Hyde?
Fava, G. A. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000074433 · Cited by 24 · cited 1×
“and corporate interests result in self-selecting academic oligarchies (special interest groups) that influence clinical and scientific information [”
BackgroundSelf-citationThe Effectiveness of Cognitive Therapy for Schizophrenia: What Can We Learn from the Meta-Analyses?
Sensky, T. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000083997 · Cited by 23
The Utility of Systematic Reviews: The Case of Psychological Debriefing after Trauma
Sensky, T. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000070780 · Cited by 20
Management of Recurrent Depression in Primary Care
Fava, G. A., Ruini, C., & Sonino, N. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000067189 · Cited by 20 · cited 1×
“Accordingly, the diagnostic criteria for a major depressive disorder identify a syndrome that may be responsive to antidepressant drugs [”
BackgroundSelf-citationBalon, R. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000073025 · Cited by 18
The Influence of psychological and social factors on accuracy of self-reported blood pressure
Horwitz, S. M., Prados‐Torres, A., Singer, B. H., & BRUCE, M. L. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00427-1 · Cited by 17
Horwitz, R. I., Singer, B. H., Makuch, R., & Viscoli, C. M. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00025-5 · Cited by 17
By Whom and How Is the Quality of Research Data Collection Assured and Checked?
Balon, R. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000087779 · Cited by 14
Is the system dumbing down research?
Gannon, F. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400407 · Cited by 6
Generalizability of antidepressant efficacy trials.
Zimmerman, M. A., Posternak, M. A., & Chelminski, I. (2004) · PubMed · Cited by 3
Research works printed but not linked: 3
- 10.1017%2FS0033291700044809 · DOI · Paper page
- 10.4088%2FJCP.v66n0112 · DOI · Paper page
- 10.4088%2FJCP.v66n0112 · DOI · Paper page
Cited by
Increasing Psychological Well‐Being and Resilience by Psychotherapeutic Methods
Fava, G. A., & Tomba, E. (2009) · Journal of Personality · doi:10.1111/j.1467-6494.2009.00604.x · Cited by 362
“An issues that is often neglected is the fact that randomized controlled trials, when transferred from their origin in agricultural research into clinical medicine and psychology, were not intended to answer questions about treatment of individual patients (Fava, 2006).”
BackgroundSelf-citationFassino, S., Pierò, A., Tomba, E., & Abbate-Daga, G. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-67 · Cited by 348
“This as yet untested approach may also lead to individualised strategies based on the fact that a treatment that is helpful to many patients may not be suitable or may even be harmful in a specific subgroup [57].”
Efficacy of cognitive behavioral therapy for chronic fatigue syndrome: a meta-analysis
Malouff, J. M., Thorsteinsson, E. B., Rooke, S. E., Bhullar, N., & Schutte, N. S. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.10.004 · Cited by 212
Early Identification and Intervention in Depressive Disorders: Towards a Clinical Staging Model
Hetrick, S. E., Parker, A. G., Hickie, I. B., Purcell, R., Yung, A. R., & McGorry, P. D. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000140085 · Cited by 186
Sirri, L., Grandi, S., & Fava, G. A. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000151387 · Cited by 131
Self-citation
Metadata
- Authors
- Fava, G. A.
- Affiliations
- University of Bologna (IT)
- Corresponding author
- Fava, Giovanni A.
- ORCID
- Fava, Giovanni A.
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2006
- Volume
- 75
- Issue
- 4
- Pages
- 202-208
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W1998527927
- Cited by
- 79
- References
- 86
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 1 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 6 · 2013: 2 · 2012: 4
- FWCI
- 100.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Ministero dell'Università e della Ricerca
- Topics
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Social Sciences › Arts and Humanities › History and Philosophy of Science › Medicine, History, and Philosophy
- Social Sciences › Psychology › Clinical Psychology › Historical Psychiatry and Medical Practices
- Keywords
- biological reductionism, clinical psychopharmacology, pharmaceutical industry influence, psychometric assessment, therapeutic process, individual treatment response, psychological well-being, clinical observation
- MeSH terms
- Mental Disorders, Health Status, Humans, Psychiatry, Psychometrics, Psychotropic Drugs, Conflict of Interest, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.